论文部分内容阅读
近年来对肺癌合并胸腔积液的18例患者采用胸腔穿刺抽液后腔内注射卡铂(CBP),使临床症状迅速缓解,且副作用小。延长了患者生存期。 1.临床资料 18例均经病理或细胞学诊断,其中腺癌10例,鳞癌5例,小细胞肺癌3例。男14人,女4人,年龄36～78岁,中位年龄67.5岁。卡劳夫斯基(KPS)评分:60～70分3例,70～80分8例,80～90分5例,大于90分2例,其中血性胸水15例,淡黄色胸水3例。 治疗方法 常规胸腔穿刺抽液,在病人能耐受的条件下,尽可能抽尽胸水,然后胸腔内注射生理盐水20ml
In recent years, 18 cases of lung cancer with pleural effusion were treated with intracavernous injection of carboplatin (CBP) after thoracentesis, which resulted in rapid relief of clinical symptoms and fewer side effects. Extended patient survival. 1. Clinical data 18 cases were diagnosed by pathology or cytology, including 10 cases of adenocarcinoma, squamous cell carcinoma in 5 cases, 3 cases of small cell lung cancer. There are 14 males and 4 females, aged 36 to 78 years old, with a median age of 67.5 years old. Kalawski (KPS) score: 60 to 70 points in 3 cases, 70 to 80 points in 8 cases, 80 to 90 points in 5 cases, more than 90 points in 2 cases, including bloody pleural effusion in 15 cases, light yellow pleural effusion in 3 cases. Treatment routine thoracentesis, in patients can tolerate conditions, as much as possible to drain pleural effusion, and then intramuscular injection of saline 20ml